The miR-212-3p/solute carrier family 6 member 1 (SLC6A1) axis has been found by Zhang et al. [24] as a possible predictive model in HCC, highlighting its significance as a therapeutic target for this illness. This evidence concerns the gene SLC6A1 and hepatocellular carcinoma.